Patents by Inventor Jan Wilschut

Jan Wilschut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic immunization against cervical carcinoma
    Publication number: 20070166328
    Abstract: An alphavirus vector system comprising nucleic acid of a human papilloma virus origin is disclosed. A method of treating or preventing cervical cancer is also disclosed. The method includes administering the alphavirus vector system and/or a cell comprising nucleic acid derived from human papilloma virus (HPV) to a subject. The alphavirus vector system or the cell may be administered as a vaccine.
    Type: Application
    Filed: March 7, 2007
    Publication date: July 19, 2007
    Applicant: Rijksuniversiteit Groningen
    Inventors: Djoeke Regts, Marijke Holtrop, Jan Wilschut, Catharina Daemen
  • Virosome-like-particles
    Publication number: 20060228376
    Abstract: The invention relates to the production of virosome-like-particles. The invention provides a method for producing a virosome-like-particle comprising contacting an enveloped virus with a solution containing a short-chain phospholipid allowing solubilisation of the viral envelope of said virus further comprising removing short-chain phospholipid from said solution allowing formation of a functionally reconstituted viral envelope.
    Type: Application
    Filed: February 11, 2004
    Publication date: October 12, 2006
    Applicant: BRANDT INDUSTRIES
    Inventors: Anke Luise Huckriede, Jorgen de Jonge, Antonius Johannes Stegmann, Pieter Schoen, Jan Wilschut
  • Functionallly reconstituted viral membranes containing adjuvant
    Publication number: 20060193873
    Abstract: The present invention relates to vaccines directed against antigens such as membrane proteins from pathogens or tumor cells. The invention further relates to methods of forming reconstituted viral membranes, with membrane fusion activity, which are lipid bilayer membranes preferably containing natural lipids of a virus, a viral fusion protein, one or more optional further antigens as well as amphiphilic adjuvants. Pharmaceutical compositions comprising such reconstituted viral membranes are also part of the invention.
    Type: Application
    Filed: June 18, 2004
    Publication date: August 31, 2006
    Applicant: BESTEWIL HOLDING N.V.
    Inventors: Antonius Stegmann, Jan Wilschut, Johannes Henricus Van Berkum